Marshall Wace, LLP Ani Pharmaceuticals Inc Transaction History

Marshall Wace, LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$58.53 - $68.82 $232,890 - $273,834	3,979 New	3,979 $253,000
Q3 2023 Nov 14, 2023	BUY	$50.28 - $64.61 $3.96 Million - $5.09 Million	78,847 Added 769.54%	89,093 $5.17 Million
Q2 2023 Aug 14, 2023	SELL	$37.29 - $53.83 $35,537 - $51,299	-953 Reduced 8.51%	10,246 $551,000
Q1 2023 May 15, 2023	BUY	$37.61 - $45.72 $421,194 - $512,018	11,199 New	11,199 $444,000
Q1 2022 May 16, 2022	SELL	$26.91 - $47.15 $1.2 Million - $2.1 Million	-44,600 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$32.97 - $56.85 $1.47 Million - $2.54 Million	44,600 New	44,600 $2.06 Million
Q2 2019 Aug 14, 2019	SELL	$67.77 - $82.2 $766,004 - $929,106	-11,303 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$45.83 - $70.54 $518,016 - $797,313	11,303 New	11,303 $797,000
Q4 2018 Feb 14, 2019	SELL	$41.17 - $56.44 $382,428 - $524,271	-9,289 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$52.95 - $71.34 $491,852 - $662,677	9,289 New	9,289 $525,000

212

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $982M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.